Speaker illustration

Doctor Haonan Sun

(China)

Reassessing pharmacological trials with positive composite outcome driven by reduction in nonfatal myocardial infarction: a systematic review and meta-analysis

Event: ESC Congress 2024

Topic: Trial Design

Session: Cardiovascular trends: hospitalisations, trials, and genetic therapies

Thumbnail